India's Nectar Lifesciences falls after European agencies flag concerns at facility
11/03/2025 04:47
** Nectar Lifesciences NECT.NS drops exchange-allowed maximum of 5% to 26.37 rupees ** European Directorate for Quality of Medicines & HealthCare and Spanish Agency of Medicines and Medical Devices issue seven observations to co's API manufacturing facility in Punjab's Mohali ** Co says it will prepare corrective action and preventive action report to address observations ** NECT falls 32.4% YTD (Reporting by Vijay Malkar) ((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Nectar Lifesciences
See all newsBrief: Nectar Lifesciences To Acquire 100% Paid- Up Equity Share Capital Of Avensis Exports
Brief: Nectar Lifesciences Approves Buyback Of Shares Valued At 810 Million Rupees
India's Nectar Lifesciences jumps on plan to consider buyback of shares
Brief: Nectar Lifesciences Proposes Buyback Of Equity Shares
Brief: Nectar Lifesciences Says Secured Debt And Interest Owed By Co Fully Repaid And Settled With Banks